Astex Pharmaceuticals Announces Presentations at Upcoming Conferences
DUBLIN, Calif.--(BUSINESS WIRE)--
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company
dedicated to the discovery and development of novel small molecule
therapeutics, today announced that James S.J. Manuso, PhD, chairman and
chief executive officer, will present at the following conferences:
BIO CEO & Investor Conference in New York on February 14th at 11:30 am
Citi Global Health Care Conference in New York on February 29th at
11:30 am ET
Live webcasts will be available in the Investor Events section of the
Company's website, www.astx.com.
The webcasts will be archived for 30 days.
In addition, Mohammad Azab, MD, chief medical officer, will be a
panelist in the BIO CEO & Investor Conference Therapeutic Workshop, "Secrets
of Oncology Success — Lessons and Trends in Phase II Clinical Trial
Outcomes" on February 13th at 10:30 am ET in New York.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of
novel small molecule therapeutics with a focus on oncology. The Company
is developing a proprietary pipeline of novel therapies and is creating
de-risked products for partnership with leading pharmaceutical
companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for
Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
Astex Pharmaceuticals, Inc.
Timothy L. Enns, 925-560-2810
Corporate Communications & Marketing
Alan Roemer, 646-378-2945
Melanie Toyne-Sewell (Europe), +44 20 7866 7866
Skye Dietrich (US), 857-241-0795
Source: Astex Pharmaceuticals, Inc.
News Provided by Acquire Media
Close window | Back to top